Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer. - Wikidata - wikimedia - TriplyDB

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

http://www.wikidata.org/entity/Q35131272

about

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?Concerning pretreatment ¹⁸F-FDG PET/CT imaging in patients with large or locally advanced breast cancer.Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2- Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study

P2860

Q36109265-0D98A233-58A8-4273-89BF-FE8B3EC32AE5 Q36949355-4A054208-61D5-46D1-8D7E-0D83B84DD38F Q37566580-3A6FCB87-495B-4A30-AC42-8D1D7129BFCC Q41507039-1363A20F-410E-4706-9337-88AF13D6C283 Q42479479-420886D9-D870-4119-A24C-BF7EDEF6F262 Q47856252-437DAB60-B113-4B6A-9D8A-BFDCA845B22C Q48047542-62F78492-50E7-41EF-9D6F-7D994C5162E7 Q50100711-89CFEE7C-D3B7-42B7-90CB-24CEB63A0F6B Q51135004-04D98BA9-4A1F-4756-9175-A0FE00D1950C Q51727954-09F651CC-3FF7-4952-9706-86917AEEF237 Q53396296-E984848B-0F08-4AF4-A525-294C9A694816 Q59129064-41C46DB7-B64C-4020-A287-6B692DFFFB3C

P2860

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

http://www.wikidata.org/entity/Q35131272

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@ast

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@en

type

label

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@ast

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@en

prefLabel

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@ast

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@en

P1433

Q35131272-9DC70F6E-FBFD-4F7A-8E16-8944074BCDDA

P1476

Q35131272-47A14F54-ABF9-4459-925A-894C6A345672

P2093

Q35131272-25EA2A7D-3193-4AD2-88C9-715C60D83019

Q35131272-3F276EB8-528E-4D48-9CE3-4F74AB899CED

Q35131272-7361055A-2397-46BC-AA21-3B741F43ADF1

Q35131272-B2BB33C0-7847-451F-9E42-439368923B75

Q35131272-C3BEB6A1-A059-41CB-85EE-AB49F6C2326E

Q35131272-C80A521B-D5CC-4D1E-8093-951C38CB0988

Q35131272-EAD0B7E1-2342-46FD-9D58-E0D56911FAB5

P2860

Q35131272-02B875AB-6793-49EA-B307-5DF28207F801

Q35131272-13823BC0-0513-40B0-A7ED-DAF53482137F

Q35131272-24B7700D-CFE5-46A5-B7BE-04190BD1519B

Q35131272-2E054474-D4EE-4807-BEC5-39EE0C767F78

Q35131272-403FF1D4-4FD5-492E-B8E1-D46AC02D5BD3

Q35131272-5346F753-4C5B-4C3A-8C87-9742322D1A07

Q35131272-5D087F38-79F2-4028-A0D3-87B140977908

Q35131272-5DBF4A0B-366D-458D-AB4D-66B75B539835

Q35131272-6088FCEA-2B72-4C08-B6CF-C14751DF0DFC

Q35131272-6840D064-72CE-45F5-9080-D52E844B5F4D

P2888

Q35131272-086FC0AA-10D5-4C39-90D2-4C45C8AFAC6D

P304

Q35131272-80CF8FA6-8635-44FC-9871-F79A1CD4AB78

P31

Q35131272-F69E1885-F668-452F-94B7-DF79C8BA1166

P356

Q35131272-B25BA353-F77B-4942-99BC-686979F9062B

P407

Q35131272-AF39BC8D-8B28-4EF2-81DE-D6EF777ADC2F

P433

Q35131272-FE138D8D-E892-4830-8318-B2E399A2DBD2

P478

Q35131272-13ED5C03-B39A-4D4F-B95C-E703D9E44210

P577

Q35131272-E4A22BA2-11FA-4B49-BC8D-60C39D05DB02

P5875

Q35131272-1B85CDAE-960F-47D9-B3CB-08F9D854F820

P698

Q35131272-B2CD7129-5E71-47A7-8676-1BD90871917C

P932

Q35131272-4AFB051A-1646-4103-94E4-0A8F47D3F5AB

P356

S10549-015-3303-9

P1433

Breast Cancer Research and Treatment

P1476

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

@en

P2093

Hideo Shigematsu

http://www.w3.org/2001/XMLSchema#string

Kenjiro Aogi

http://www.w3.org/2001/XMLSchema#string

Morihito Okada

http://www.w3.org/2001/XMLSchema#string

Norio Masumoto

http://www.w3.org/2001/XMLSchema#string

Sachiko Kiyoto

http://www.w3.org/2001/XMLSchema#string

Takayuki Kadoya

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Sugawara

http://www.w3.org/2001/XMLSchema#string

P2860

Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence.

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

P2888

s10549-015-3303-9

P304

209-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3303-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272518079

http://www.w3.org/2001/XMLSchema#string

P698

25697596

http://www.w3.org/2001/XMLSchema#string

P932

4344554

http://www.w3.org/2001/XMLSchema#string